top of page
Debunking Myths on Hyaluronic Acid Injectable Gels in Clinical Practice
Navid Alizadeh, Silvia Caboni, Karl Hasenöhrl, Zbigniew Paul Lorenc, Paula Rosso Millan, Billur Sezgin Kizilok, Fang-Wen Tseng, Lee Walker Image Credit: © Dusko - stock.adobe.com Background: Hyaluronic acid (HA)–based soft-tissue fillers are the most widely used injectables for nonsurgical facial rejuvenation, valued for their reversibility, versatility, and safety profile. Despite widespread use, misconceptions about HA gels have proliferated on social media and in clinical
Dr. Lorenc Featured at ASJ Journal Club
We're proud to share that Dr. Lorenc recently participated in the Aesthetic Surgery Journal Journal Club — a premier forum for expert discussion on the latest in aesthetic surgery research and technique.
A New Chapter in Breast Reconstruction: What Conexeu's B.R.E.A.S.T.™ Could Mean for Patients
Regenerative medicine has long promised more than implants and repair could deliver. Conexeu is working to make that promise real in breast reconstruction, and I am proud to be part of that effort.
Not All Neck Lifts Are Created Equal
When patients come to me asking about neck rejuvenation, one of the most common questions I hear is: "I've seen something called My Ellevate online - is that what you do?" The short answer is no.
Commentary on: Use of LetibotulinumtoxinA for AestheticTreatment of Asians: A Consensus
Aesthetic Surgery Journal, Volume 43, Issue 11, November 2023, Pages NP975–NP976, https://doi.org/10.1093/asj/sjad224 Published: 01...
Galderma unveils final nine-month data showing lasting efficacy with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight Loss
Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss
The Face of Emotion: Botulinum Toxin, Emotional Anatomy, and Mood Modulation
Robert J. Vanaria1,2 | Aysham Chaudry1 | Angelica C. Marrero-Perez1 | Z. Paul Lorenc3 | Mark S. Nestor1,4,5 ABSTRACT Background: Facial...
Commentary on: Use of LetibotulinumtoxinA for Aesthetic Treatment of Asians: A Consensus
Z. Paul Lorenc, MD, FACS It was with great interest that I read the consensus article by Liu et al on the use of letibotulinumtoxinA for...
Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
Steven Dayan MD1 | John Joseph MD2 | Amir Moradi MD, MBA3 | Z. Paul Lorenc MD, FACS4 | Kyle Coleman MD5 | Glynis Ablon MD, FAAD6 | Joely...
Straight-Line Vector Planning for Optimal Results With Silhouette InstaLift in Minimally Invasive Tissue Repositioning for Facial Rejuvenation
Z. Paul Lorenc MD FACS, David Goldberg MD JD, &.MArk Nestor MD PhD
Treatment Options in Facial and Nonfacial Volumization: An Introduction to Poly-L-Lactic Acid
Danny Vleggaar MD, Rebecca Fitzgerald MD, and Z. Paul Lorenc MD FACS
Validating a Series of Photonumeric RatingScales for Use in Facial Aesthetics UsingStatistical Analysis of Intra- and Inter-raterReliability
Z. Paul Lorenc, MD, FACS; Derek Jones, MD; Jeongyun Kim, MS;
Hee Min Gwak, MS; Samixa Batham, MBBS; and Ginny Vachon, PhD
The Second of Two One-Year, Multicenter,Open-Label, Repeat-Dose, Phase II SafetyStudies of PrabotulinumtoxinA for theTreatment of Moderate to Severe GlabellarLines in Adult Patients
Z. Paul Lorenc, MD, FACS; Jeffrey M. Adelglass, MD, FACS;
Rui L. Avelar, MD; Leslie Baumann, MD; Kenneth R. Beer, MD;
Joel L. Cohen, MD; S
Skin Tightening With Hyperdilute CaHA: Dilution Practices and Practical Guidance for Clinical Practice
Z. Paul Lorenc, MD, FACS; Jeanette M. Black, MD; Jessie S. Cheung, MD, FAAD; Annie Chiu, MD; Roberta Del Campo, MD; Alan James Durkin,...
Rheological Properties of Calcium Hydroxylapatite with Integral Lidocaine
Z. Paul Lorence MD, Mellissa Meland BS, Chris Groppi MS
bottom of page